Back to BAILLIE GIFFORD & CO BAILLIE GIFFORD & CO

NVCRNVCR

Showing 8 of 30 quarters

Position history for BAILLIE GIFFORD & COBAILLIE GIFFORD & CO's holdings in NOVOCURE LTD

Yes. Baillie Gifford holds 952,074 shares of NVCR (Novocure), worth $14.4M, as of its Q2 2026 13F filing. It reduced the position by 119,510 shares (-11.2%) from Q1 2026. Baillie Gifford has held NVCR in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$14.4M

Current Shares

952,074

Total Value Change

-$11.5M

Total Shares Change

-707,240

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
952,074
-11.2%
$14.4M0.0%$15.15
0
2026-Q1
Decreased
1.1M
-4.4%
$11.7M0.0%$10.90
0
2025-Q4
Decreased
1.1M
-0.3%
$14.5M0.0%$12.93
0
2025-Q3
Decreased
1.1M
-0.4%
$14.5M0.0%$12.92
0
2025-Q2
Decreased
1.1M
-0.7%
$20.1M0.0%$17.80
0
2025-Q1
Decreased
1.1M
-2.1%
$20.3M0.0%$17.82
0
2024-Q4
Decreased
1.2M
-30.0%
$34.6M0.0%$29.80
0
2024-Q3
Decreased
1.7M
-1.7%
$25.9M0.0%$15.63
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used